Compare ACGL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACGL | DXCM |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | Bermuda | United States |
| Employees | 8000 | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8B | 28.1B |
| IPO Year | N/A | 2005 |
| Metric | ACGL | DXCM |
|---|---|---|
| Price | $97.64 | $70.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $108.50 | $85.33 |
| AVG Volume (30 Days) | 2.3M | ★ 5.0M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $3.34 | $12.31 |
| P/E Ratio | ★ $8.45 | $134.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $82.45 | $54.11 |
| 52 Week High | $102.90 | $89.07 |
| Indicator | ACGL | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 65.76 | 46.20 |
| Support Level | $91.44 | $62.86 |
| Resistance Level | $97.25 | $74.08 |
| Average True Range (ATR) | 1.66 | 2.66 |
| MACD | 0.77 | -0.99 |
| Stochastic Oscillator | 98.41 | 9.78 |
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.